Back to results
US 8,530,180 B2Granted
Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
AssigneeChiesi Farmaceutici S.p.A.
InventorsDominic M. Desiderio, Xianquan Zhan
Life of this patent
Estimating the term…
Abstract
Specific nitroprotein biomarkers may be used as prognostic and diagnostic tools for COPD. Identification of certain specific nitroprotein biomarkers allows the development of targeted therapies aimed at prevention and treatment of COPD.
Claims9
A method for identifying a smoker or an ex-smoker human being at risk of developing chronic obstructive pulmonary disease (COPD), comprising:
- (i) obtaining from said human being a biological sample in which one or more nitroproteins result from an inflammatory response in the lung causing formation of nitric oxide (NO) free radical which reacts with superoxide anion (O2−) to form nitrosant peroxynitrite anion (ONOO−) which causes addition of nitrite (NO2) to protein tyrosine residues;
- (ii) conducting proteolytic cleavage of said one or more nitroproteins in said sample with a suitable protease to generate nitropeptides;
- (iii) selectively identifying the presence or absence of the nitropeptide of SEQ ID 1 in said sample;
- and
- (iv) identifying the patient as being at risk of developing COPD if said nitropeptide of SEQ ID 1 is present in the sample.
2 more elements
Dependencies are inferred from the claim text.